World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Tzouvala M, Zacharopoulou E, Kalafateli M, Viazis N, Psistakis A, Theodoropoulou A, Drygiannakis I, Karmiris K, Koutroubakis IE, Kevrekidou P, Soufleris K, Katsaros M, Giouleme O, Fousekis F, Katsanos K, Christodoulou D, Gaki A, Papathanasiou E, Bamias G, Zampeli E, Michopoulos S, Kyriakos N, Veretanos C, Argyriou K, Kapsoritakis A, Tribonias G, Mantzaris GJ, Liatsos C. Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study. World J Gastroenterol 2025; 31(42): 111282 [PMID: 41278164 DOI: 10.3748/wjg.v31.i42.111282]
URL:	https://www.wjgnet.com/1007-9327/full/v31/i42/111282.htm

For:

Tzouvala M, Zacharopoulou E, Kalafateli M, Viazis N, Psistakis A, Theodoropoulou A, Drygiannakis I, Karmiris K, Koutroubakis IE, Kevrekidou P, Soufleris K, Katsaros M, Giouleme O, Fousekis F, Katsanos K, Christodoulou D, Gaki A, Papathanasiou E, Bamias G, Zampeli E, Michopoulos S, Kyriakos N, Veretanos C, Argyriou K, Kapsoritakis A, Tribonias G, Mantzaris GJ, Liatsos C. Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study. World J Gastroenterol 2025; 31(42): 111282 [PMID: 41278164 DOI: 10.3748/wjg.v31.i42.111282]

URL:

https://www.wjgnet.com/1007-9327/full/v31/i42/111282.htm

(53) (52) (0) (0) (0) (16) (997) (3)

Number	Citing Articles
1	Jonathan Soldera, Maria Antonia Selbach Pertile, Leticia Nodari Carobin, Daniel Jun Funatsu Brambilla, Eduardo Brambilla. Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(3): 120771 doi: 10.4292/wjgpt.120771 Abstract(23) \| Core Tip(23) \| Full Article(HTML)(111) \| Full Article (PDF)-3971K(22) \| Full Article with Cover (PDF)-4306K(7) \| Full Article (XML)-175K(9) \| Audio-157K(3) \| Peer-Review Report-231K(8) \| Answering Reviewers-155K(11) \| Times Cited (0) \| Total Visits (196) \| Open
2	Yasser Fouad, Ahmed S Aboelela. Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis. World Journal of Gastroenterology 2026; 32(9): 115785 doi: 10.3748/wjg.v32.i9.115785 Abstract(91) \| Core Tip(99) \| Full Article(HTML)(648) \| Full Article (PDF)-405K(194) \| Full Article with Cover (PDF)-1786K(101) \| Full Article (XML)-62K(49) \| Audio-1895K(11) \| Peer-Review Report-181K(54) \| Answering Reviewers-107K(47) \| Times Cited (0) \| Total Visits (1061) \| Open
3	R. Gilmore, T. Pham, R. G. Fernandes, S. Lo, E. K. Wright, O. Rosella, P. De Cruz, B. Andrew, A. Vasudevan, K. Gazelakis, G. T. Moore, L. Thin, K. Au, S. Ghaly, C. Chen, W. Mohsen, T. Goodwin, M. P. Sparrow, M. G. Ward, M. Chew, M. Garg, E. Shelton, I. C. Lawrance, A. Thorat, C. da Fonseca Pereira, J. Begun, Y. K. An. Extended High‐Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study. JGH Open 2026; 10(5) doi: 10.1002/jgh3.70410